






LFifty years of cardiothoracic surgery through the looking glass and what
the future holds
Marko Turina, MD
EDITORIALTurina EditorialThose who cannot remember the past are condemned
to repeat it.
George Santayana
I thank the Association and its President Craig Miller for
the honor of inviting me to address the meeting. I will con-
centrate on the topic that captivated my interest for many
years. Some of you might be skeptical about such a talk,
and I do not blame you. We have all sat through the tedious
ramblings of elderly surgeons, sometimes coupled with bad
jokes, and hoped that their talk would not be too long.
I will try to show you that it is not only interesting but also
important to study the history of our profession. One of the
famous quotations by Spanish-born American philosopher
George Santayana also holds true in our profession: ‘‘Those
who cannot remember the past are condemned to repeat it.’’
Forgotten facts can lead to problems in recent innovations,
when previous experiences are disregarded by the younger
generation. I will mention only 2 recent examples. Paraster-
nal incision for minimally invasive approach to the aortic
valve can result in a disturbing and difficult to treat lung her-
niation. The fact was well known in the 1960s and is only
being rediscovered now. Equally important, a proximal cor-
onary stenosis can develop when coronary arteries are can-
nulated for continuous coronary perfusion. This might
cause intimal hyperplasia and lead—in the years after the
first operation—to a potentially lethal left main stenosis.
This fact was first published in 1976, and I am worried
that the newly ‘‘rediscovered’’ method of beating heart
valve replacement with direct coronary artery perfusion
might lead to the same kind of late complications.
Another lesson from studying the history of our profes-
sion is a profound distrust of claim of primacy. It is generally
difficult to present something as truly new, as a detailed de-
scription of an oxygenator from the Archives of Physiology
in 1885 shows.1 The device was constructed by 2 physiolo-
gists, von Frey and Gruber, for perfusion of isolated organs,
but bears uncanny resemblance to the modern heart–lung
machines, with temperature and volume control, and a de-
airing device.
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CONDITIONS FOR DEVELOPMENT OF CARDIAC
SURGERY
There is a general perception that the development of our
profession was made possible by the progress in related sci-
ences, by the discovery of endotracheal intubation and ad-
vances in anesthesia, by the discovery of heparin and its
rapid reversal by protamine, by the establishment of inten-
sive care units, and by similar developments in related fields.
I submit that 2 other aspects were equally important. First,
our profession was born and progressed only under socio-
economic conditions favoring innovative development.
Second, the birth of cardiac surgery depended on the emer-
gence of courageous, creative pioneers who were willing to
apply their experimentally acquired knowledge to clinical
practice.
Considerable research in the field of heart surgery was
performed in the 1930s, but socioeconomic conditions
were not favorable for the clinical application of revolution-
ary developments, such as the pump oxygenator. Moreover,
the development was dependent on financial support, which
faded during turbulent times preceding World War II, with
its financial crisis, depression, widespread unemployment,
and political upheaval. Two famous men collaborated in
the 1930s on the development of a pump oxygenator at
Rockefeller Institute in New York: Nobel Prize winner
Alexis Carrel and the famous flyer Charles Lindbergh, the
first person to fly nonstop across the Atlantic from New
York to Paris. Their work was overshadowed by the major
economic depression in the United States, gradually involv-
ing the whole world, with massive unemployment and social
turmoil.
Another example of the profound effect of socioeconomic
factors on scientific development can be observed when
studying the development of cardiac surgery in the previous
Soviet Union. Some important discoveries remained totally
unknown in the scientific community because of that
country’s political isolation, domestic terror, and lack of
international contacts. The work of Sergei Sergeevich
Brukhonenko, so ably reviewed by Konstantinov and
Alexi-Meskishvili,2 led to the early development of an oxy-
genator, first using the autologous lung and from 1936 on-
ward using a bubble oxygenator, which even now looks
surprisingly similar to the devices developed 30 years later.
This work received no attention and lacked—even in his
own country—any clinical impact. The lesson is obvious:
Without freedom, scientific development stagnates. Terrible
years of purges and gulags in the Soviet Union also exacted







LDISAPPEARANCE OF EUROPEAN DOMINANCE
IN THE FIELD OF SURGERY
It is currently forgotten that before World War II, German,
British, and French surgical units were considered to be the
most advanced, and young aspiring American surgeons usu-
ally spent 1 or 2 years in Europe. The reverse happened after
World War II, when most of the aspiring European surgeons
underwent part of their training in the United States. For ex-
ample, the late Dr Michael DeBakey, destined to become
one of the most prominent cardiac and vascular surgeons
in the world, after finishing his surgical training, elected to
improve his knowledge by visiting Leriche in Strasbourg
and Sauerbruch in Berlin. Dr Alton Ochsner, who later
founded this premier institution, Ochsner Clinic in New Or-
leans, spent a part of his training in Zurich, Switzerland.
The turbulent 1930s witnessed the emergence of totalitar-
ian regimes, with their mass indoctrination, political intoler-
ance, and racial discrimination, which in turn provoked
a tremendous brain drain on European science, the United
States in particular profiting from this development. During
World War II, which exacted not only the tremendous mate-
rial but also a heavy human cost, the scientific advances in
Europe practically seized. The important work of Lawrence
O’Shaugnessy3 on the surgical treatment of cardiac ische-
mia, which also led to the formation of the Lambeth Cardio-
vascular Clinic in London (in the 1930s!), came to the end in
the inferno of Dunkirk, during the retreat of the British Army
from France in summer of 1940, when O’Shaugnessy was
killed by a stray bullet while working on the next edition
of his book.
Some important work was performed in safe heavens be-
fore or during World War II. Robert Gross’s4 work in Boston
on the closure of patent duct was published in 1939, but his
work remained largely unknown to the rest of the world in
the turmoil of World War II. Equally revolutionary was
Clarence Crawfoord’s5 resection of coarctation, which he
had to submit in 1944 to an obscure Swedish journal, having
no other publishing choice. The scientific interaction was in-
terrupted during the war, international mail contact was
barely possible, and travel across the Atlantic was risky;
one did not attend the meetings or meet the colleagues for
an exchange of ideas.
US DOMINANCE IN THE FIELD OF CARDIAC
SURGERY
Emerging victorious and, with the exception of loss of
lives in the armed forces, largely unscathed from World
War II, the United States entered a period of unprecedented
prosperity, which also initiated a period of tremendous ad-
vance in science. Dr Blalock achieved world fame with his
palliative procedure for tetralogy of Fallot, considered
even decades later by many to be almost curative in its ef-
fects. After a long preparatory work in the laboratory, the de-1118 The Journal of Thoracic and Cardiovascular Suvelopment of cardiac surgery really began in the 1950s. One
of the most extraordinary series of successful operations was
performed by the late Dr Lillehei in Minneapolis, using
cross-circulation, with an adult, usually a parent of the pa-
tient, acting as the circulatory donor. The Minneapolis group
used the azygos principle: The patient can be kept alive and
survive for a limited period of time on a surprisingly small
amount of blood flow of approximately 10 mL/kg/min.
One should remember that the working conditions in cardiac
surgery were extremely primitive in the early 1960s (Fig-
ure 1). There was a single-channel oscilloscope for monitor-
ing. Surface-induced hypothermia was used for atrial septal
defect closure, using inflow occlusion, which gave exactly 3
minutes to complete the repair and close the atriotomy, the
anesthetist being instructed to count 30-second intervals
out loud. Total correction of more complex anomalies was
performed in infants with Mohri and colleagues’6 technique
of water-bath cooling until cardiac arrest occurred. The chest
was opened—with the infant’s body still immersed in cold
bath—and the patient was further cooled with gentle cardiac
massage to 24C to 25C . At this point, the massage was
stopped, the quiet heart was opened, and the surgical repair
(atrioventricular canal, ventricular septal defect, or transpo-
sition of great arteries [TGA]) was performed. Thereafter,
the cardiotomy was closed and the patient was rewarmed,
first with cardiac massage and later with natural circulation,
introducing warm water in the bath and warm saline in the
chest.
The rapid introduction of experimental advances into clin-
ical practice led to the marked American dominance in the
field of thoracic surgery in the 1960s. All these pioneers,
who need no introduction to the audience, led the world in
advancing our profession to unprecedented levels. The
1960s were also times of unbridled optimism, with nuclear
power promising to be an unlimited source of energy. It is
therefore no surprise that nuclear energy was seriously con-
sidered for a heart-assist device. Such units were constructed
under the Artificial Heart Program in the 1960s and early
1970s, using plutonium 238 as an energy (heat) source
and the Sterling steam (!) engine for power conversion.7
Much of this progress was made possible, of course, by
the generous funding of the National Institutes of Health,
which still continues today (Figure 2). This strong financial
support led to the American dominance in the field of sci-
ence, reflected in the statistics of the most quoted articles.
US dominance is also visible in the overall statistics of sci-
entific publications. Nobel prizes for science are awarded
in the United States with a predictable regularity, although
the recent trend8 suggests the emergence of Asian scientists
(Figure 3).
The late John Kirklin,9 in his address to the European
Association for Cardiothoracic Surgery in 1990, considered
the period from 1954 to 1970 in thoracic surgery as the one








LFIGURE 1. Working conditions in the early 1960s: single-channel oscilloscope, surface-induced hypothermia with a rubber blanket for atrial septal defect
closure, and total body immersion for deep hypothermia in infants. ECG, Electrocardiogram.consolidation, and he hoped that the last years of the century
would be devoted to scientific development. Few people ex-
pected the sudden onset of new developments in our own
and related professions, with victorious emergence of percu-
taneous coronary interventions, which led to the substantial
reduction in coronary bypass grafting procedures. Some
prominent cardiologists predicted the disappearance of cor-
onary artery bypass grafting for treatment of angina. A side
effect of this development is the overall reduction in the
number of practicing thoracic surgeons, the difficulties in
filling thoracic residencies, and the aging of practicing tho-
racic surgeons.
EMERGENCE OF NON-US INNOVATIONS IN
CARDIAC SURGERY
Another interesting phenomenon is that for the first time
in the short history of our profession, an increasing number
of new developments are now taking place outside of the
United States. Just as a ‘‘pars pro toto’’ example, the first
extensive trials of off-pump coronary artery grafting took
place in Argentina and Brazil by Sani and colleagues10
and Buffolo and colleagues.11 A similar trend is presently
being observed in the field of percutaneous and transapical
valve implantations. It should also not be forgotten that
the use of internal thoracic artery and coronary surgery with-
out the use of cardiopulmonary bypass was really pioneered
by Vassily Ivanovich Kolessov12 in Leningrad in the 1960s.The Journal of Thoracic and CIt is interesting to analyze the reasons for such a shift of
scientific advances away from the United States, the country
that has dominated the field of thoracic surgery from its very
beginning. Several mechanisms might contribute to this phe-
nomenon. First, there is an obvious and increasing amount of
governmental interference in the mistaken belief that the
population must be ‘‘protected’’ from irresponsible medical
and surgical experimentation, a fear happily encouraged by
the mass media. Second, we are all increasingly aware of our
medical liability and—even worse—of the threat of legal
sanctions when one can be found to use an ‘‘unproven’’
method. Third, there is an exceeding pressure by health
care providers who are refusing payment for so-called un-
proven procedures, effectively canceling some of the impor-
tant recent trials.
The fact remains that the medical liability is becoming
a major financial problem, and it acts as a brake on the
new developments in surgery. For example, Jatene and col-
leagues’13 seminal article of the arterial correction of TGA
was published in 1982 and led many of us to change the
technique of TGA correction from atrial to arterial switch.
In this publication, the observed overall operative mortality
was 51%, which was reduced to 17% in the later part of his
series. This was at the time when Dr Mahony’s group14 in
San Francisco (and we in Zurich as well) were achieving
zero mortality with atrial correction in infants and newborns.







LNorth America or Europe: One might lose the license, be
struck with monumental damage claims, and even land in
jail. Still, it was this courageous work by Jatene and col-
leagues, which incidentally took place after painstaking an-
atomic studies, that made us all to move from atrial to arterial
correction of TGA, which quickly became the standard
method of repair and ushered in the modern era of TGA
surgery.
DIFFICULTIES ENCOUNTERED BY THE
INNOVATORS
Our profession obviously depended, and still depends, on
courageous innovators. They succeed because they did not
accept established dogmas, they did not believe the experts,
and they persisted despite widespread criticism. But they
did not have it easy! Woodrow Wilson said it succinctly:
‘‘If you want to make enemies, try to change something.’’
Albert Einstein, who also encountered difficulties in his
early times, stated that ‘‘the great spirits have always en-
countered violent opposition from mediocre minds.’’ The
late Walton Lillehei15 made his witty but pertinent comment
about the 7 stages of scientific discovery. In the idea stage, it
is rejected because it is claimed that it will not work or has
been tried before. After successful animal experiments, your
critics claim that it will not work in humans. After a first suc-
cessful clinical application, their only comment is that it is
a real tragedy because ‘‘now they will continue.’’ After 4
or 5 clinical successes, it is considered by the critics as
highly experimental and unethical, and it is whispered that
‘‘they have a number of deaths they are not reporting.’’ Af-
ter 10 to 15 patients, the criticism is still there, with the
claim that most of the patients did not need the operation
anyway. After a large series of success, your critics will
claim that somebody in Shangri-La has been unable to du-
plicate the results. In the final stage of a scientific discovery,
when the method has become established, your critics will
FIGURE 2. National Heart, Lung and Blood Institute research support in
the United States in the last 5 decades, in million dollars. National Heart,
Lung and Blood Institute (www.nih.gov/about/almanac/appropiations/
index.htm).1120 The Journal of Thoracic and Cardiovascular Sustate that they had the same idea much earlier, but they
did not publish anything and lacked antibiotics, anesthesia,
and other technical help. It is obvious that the life of an in-
novator is not a simple one.
It must be remembered that some of the most important,
truly revolutionary work in surgery was violently opposed
by its leaders. Ludwig Rehn displayed considerable courage
when he performed (and reported) the first suture of the
heart wound in 1896. The established opinion, expressed
by the leaders of the profession, was that the surgeon who
attempts to operate on the heart may be certain to lose the
esteem of his or her colleagues forever. It is not quite
correctly attributed to Billroth,16 the originator of gastric
surgery, but it was the predominant opinion at the time
when Rehn performed his successful closure of the ventric-
ular perforation. One of the later giants of thoracic surgery,
Ferdinand Sauerbruch, explored the idea of operating on the
open chest in a spontaneously breathing subject by putting
the surgeon and the rest of body in a low-pressure chamber
to prevent collapse of the lung. He was forced to stop his
experimental work and had to leave his position. In the
late 19th and early 20th centuries, our profession, especially
in Europe, was dominated by towering personalities who
exerted an enormous influence in their field. A classic exam-
ple of courageous innovation is the pioneering work of
Werner Forssmann in heart physiology. He became inter-
ested in studying circulation in the right side of the heart
and, although forbidden by his chief, he managed to find
a nurse to assist him in performing a cut-down on his own
cubital vein and to introduce a long urinary catheter into
his chest. He then got up, walked a considerable distance
to the x-ray department, stood in front of the fluoroscopy
screen with a mirror, and advanced the catheter into his right
atrium, finishing with an injection of contrast medium. After
he published his findings, he lost his job, had to leave
FIGURE 3. World scientific output. With permission from von Bubnoff A.








Lphysiology, was retrained as urologist, and was greatly
surprised when he was finally honored—a full 27 years
later—by receiving the Nobel prize in medicine.
When observing the work of these great pioneers, I am
always reminded of British Prime Minister David Lloyd
George’s laconic dictum: ‘‘Be brave, you cannot cross
a chasm in two small jumps.’’ I had the opportunity to
work closely with a man who, although not a surgeon,
profoundly changed our profession: My charismatic friend,
the late Andreas Gru¨ntzig, who never bothered to take his
boards in radiology, internal medicine, or cardiology, had
the vision to dilate coronary arteries with a self-made,
high-pressure balloon. It was indeed impressive to observe
a high-grade coronary lesion disappear after a single balloon
inflation with a perfectly normal vessel in the consecutive
repeat angiographies. It is not well known that the path to
success was thorny: In the first series of percutaneous trans-
luminal coronary angioplasty in Zurich, there was a 7.5%
incidence of major life-threatening complications. All of
these patients required emergency surgical rescue, some-
times under resuscitation,17 and we were proud that not
a single patient died of angioplasty complications.
By observing these innovators, several facts become obvi-
ous: Being a genius is by itself not sufficient. In addition to
purposeful tenacity and single-mindedness, the innovators
also need a supportive climate and must be able to deal
with inevitable reverses. Even harder to bear is that there
might be a substantial human cost in many innovations in
our field.
WHICH DIRECTION IS CARDIAC SURGERY
GOING?
We live in a rapidly changing world, so aptly termed the
‘‘death of distance’’ phenomenon (Frances Carrington, The
Economist 1997): internationalization of production, tre-
mendous increase in overall mobility, and explosive growth
of readily available knowledge. It is equally obvious that the
population is rapidly aging, and this phenomenon will soon
assume staggering proportion: In the United States alone, 77
million people are expected to be more than 65 years of
age by 2040. As a result, the average age of patients who
undergo coronary artery bypass grafting is continuously
increasing, and we must strive to adjust our techniques ac-
cordingly. Another unexpected phenomenon, but the one
that has substantial impact on cardiac surgery, is a surprising
reduction of cardiovascular mortality, which approaches
50% in some of the highly developed European countries,
Australia, and Canada. This trend has been observed for sev-
eral decades and is probably a multifactorial event; interest-
ingly enough, there is no change in the mortality of patients
with other disease conditions, such as malignancies. It is
obvious that the number of coronary artery bypass graft sur-
geries is continuously decreasing not only because of the re-
duced incidence of cardiovascular disease but also becauseThe Journal of Thoracic and Caof the large-scale application of percutaneous 2coronary
interventions.
Patients obviously prefer percutaneous procedures, even
with a questionable long-term benefit, and we should listen
carefully to this message. We should note what patients cur-
rently expect: to undergo a quick, painless procedure with no
incision and to leave the hospital the next day at the latest.
They do not seem to listen when we try to convince them
that our more extensive surgery might offer benefits 3 to 5
years later.
We must observe the tremendous advances in transcath-
eter endovascular procedures, both in the abdominal and
the thoracic aorta, and in peripheral vascular surgery, with
impressive control of aneurysm penetration or rupture in el-
derly patients, who would otherwise be exposed to major op-
erative mortality and morbidity.
It is equally impressive to observe Dr Walther in Dr
Mohr’s department perform this quick, beating-heart aortic
valve replacement by the transapical route without cardio-
pulmonary bypass and aortic crossclamping, with a perfect
hemodynamic result, the elimination of pressure gradient,
and well-established coronary perfusion.
DISAPPEARING AREAS OF CARDIAC SURGERY
We must accept the fact that large areas of cardiac surgery
are rapidly disappearing, and we have to adjust our units and
training to the changing conditions. It is obvious that we are
losing the following:
 A substantial proportion of coronary surgery is being re-
placed by percutaneous interventions and possibly by
the emerging techniques of angiogenesis and related ad-
vances in molecular genetics.
 Atrial septal defect and patent ductus arteriosus closure
are gone from the surgical repertoire, except as part of
the correction of complex anomalies or in very small in-
fants. Transcatheter techniques are firmly established
and are being used in increasingly questionable indica-
tions.
 Aortic coarctation, both as recurrent and de novo disease,
is increasingly being treated with balloon dilatation and
covered stents, although long-term observation, espe-
cially in unprotected dilatation, is presently lacking.
 Mitral and pulmonary stenosis in the developed nations is
not being seen by surgeons: Catheter dilatation has com-
pletely taken over the treatment of this condition.
 Arrhythmia surgery (Wolff-Parkinson-White syndrome,
ventricular ablation, and atrial flutter) is an established do-
main of electrophysiologically trained interventionists
who have also completely taken over the pacemaker and
defibrillator implantations, previously the work of cardiac
surgeons. The transcatheter treatment is even being ex-
tended to atrial fibrillation, despite reported complica-







Lelectrophysiologic procedures is the concomitant open or
closed coronary, valve, or congenital heart correction.
 Pulmonary valve replacement is successfully being re-
placed by the catheter technique, despite some present
limitations in the size of the valve that can be implanted
via catheter.
 Thoracic aortic aneurysms are rapidly disappearing from
the surgical repertoire and are being treated with endo-
vascular procedures. Here, a true benefit is already being
observed when applying this minimally invasive, percu-
taneous approach in aged, polymorbid patients.
 Aortic valve stenosis is currently treated by transfemoral
and transapical valve replacement, avoiding the inherent
morbidity of cardiopulmonary bypass, aortic manipula-
tion, and prolonged intensive care unit stay: Patients leave
the hospital the next day!
 On the horizon is the treatment of mitral incompetence,
with various percutaneous procedures. The next few years
will bring surprising advances in this field too.
HOW SHOULD CARDIAC SURGERY REACT TO
EXTRAORDINARY CHANGES IN THE
PROFESSION?
We should heed the advice of Charles-Maurice de Tall-
eyrand, famous French diplomat of the Napoleonic era:
‘‘The art of statesmanship is to foresee the inevitable and
to expedite its occurrence.’’ Resting on past laurels, quoting
our superior long-term surgical results, and adding small
changes to our practice (switching to off-pump surgery, ap-
plying valve repairs instead of replacement, using total arte-
rial revascularization) are not enough! We must again
capture the leadership in cardiac innovations, which we so
readily gave away to our colleagues in cardiology and radi-
ology. We must again lead the developments in percutane-
ous valves and endografts, and arrhythmia procedures. We
should explore the possibilities offered by cardiac genomics
and applied molecular biology. We should grasp the oppor-
tunities offered by the advances in robotics and circulatory
assistance. Because surgeons (with rare, honorable excep-
tions) cannot be basic scientists and competent clinicians
at the same time, we should place our highest priority on
translational science, enabling rapid and safe application
of newly gained knowledge to the care of our patients. To1122 The Journal of Thoracic and Cardiovascular Suachieve these long-term goals, there is need for an urgent,
overdue change in training future thoracic surgeons. As
a first step, percutaneous and catheter-based techniques
must become part of the curriculum, even if it means spend-
ing up to 1 year away from the operating theater. For a stra-
tegic objective, we should strive to create our new
professional profile: the surgical interventionist, a competent
clinician familiar with both open and percutaneous proce-
dures and able to offer the best treatment for his or her
patients.
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